Precipio to Develop Brain Tumor Panel with HemeScreen Technology
Precipio Inc. and an academic healthcare institution will jointly develop a panel for Glioblastoma based on Precipio’s HemeScreen technology.
Read More
Search Results for: liver disease
Companies Partner on Alzheimer’s Disease Diagnostic Using Optimer Binders
Aptamer Group plc and Neuro-Bio have developed Optimer binders to enable a lateral flow test for the early diagnosis of Alzheimer’s disease.
Read More
Future Ready: The Impact of Automation on Clinical Chemistry
The onus is on clinical laboratories to process a high volume of clinical chemistry tests as efficiently and accurately as possible.
Read More
MDS Diagnosed with Peripheral Blood Using HemeScreen Panel
Precipio’s HemeScreen Cytopenia panel enabled a patient’s diagnosis without the need for a painful, invasive bone marrow biopsy.
Read More
Blood Test Predicts Severe Preeclampsia Earlier, More Accurately
The test can be used between 23 and 35 weeks of pregnancy to predict development of severe preeclampsia among women who have symptoms of, or have been diagnosed with, hypertension during pregnancy.
Read More